TLX3 and acute lymphoblastic leukemia: This finding was expected, as TAL-LMO is the most represented subgroup of T-ALL.24 Good responders included xenografts belonging to either TLX1/TLX3 or the TAL1-LMO subgroups, whereas poor responders were exclusively allocated to the TAL-LMO subgroup.